Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
Top

12-09-2022 | GLP-1 agonists | Ask the expert | Article

Initiating GLP-1 receptor agonists: Managing side effects

print
PRINT
insite
SEARCH

Specialist nurse Nicola Milne discusses the side effects that can arise in people with type 2 diabetes during initiation of GLP-1 receptor agonists, and how to best manage them (7:12).

External Content

Click Play to display this content and agree to third party cookies. (>)

Update your current cookie settings.

View or download the titration guidance 

Download the high resolution version

About the expert

Nicola Milne is a Primary Care Diabetes Specialist Nurse, working across primary care networks (PCNs) and within the wider community to give support and education to all health care professionals (HCPs) in the delivery of optimal and holistic care to adults living with type 2 diabetes.


Full biography

print
PRINT

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

Watch the video

Related content

28-04-2020 | GLP-1 agonists | News

Early findings suggest route to GLP-1 receptor agonism with less gastrointestinal discomfort

03-07-2019 | Semaglutide | At a glance | Article

A quick guide to the PIONEER trials

07-02-2022 | Dulaglutide | At a glance | Article

A quick guide to the AWARD trials

11-02-2021 | Semaglutide | At a glance | Article

A quick guide to the STEP trials
Image Credits